Dr Huah Shin Ng

School of Allied Health and Human Performance

College of Health


Dr. Huah Shin Ng is currently an Adjunct Researcher at UniSA and a Practitioner Fellow at Flinders University. She is also a pharmacist with experiences working in both hospital and community settings. Her current research focuses on cancer survivorship and cancer pharmacoepidemiology.
Huah Shin has recently completed her postdoctoral research training at the University of British Columbia, Canada (2019-21) with her research focused on the assessment of the real-world safety profiles and effectiveness of disease-modifying drugs in the multiple sclerosis population (funded by the Multiple Sclerosis Society of Canada’s endMS Post-Doctoral Fellowship, the Michael Smith Foundation for Health Reserach Trainee Award and the Canadian Institutes of Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program).
Her research interests include pharmacoepidemiology, medication safety and effectiveness, and chronic diseases (cancer and multiple sclerosis).

Year Citation
2025 Ng, H. S., Johansen, C., Li, M., Roder, D., Beckmann, K., & Koczwara, B. (2025). Patterns of medication use following breast cancer diagnosis: an Australian population-based study.. Supportive Care in Cancer, 33(8, article no. 668), 1-11.
DOI
2020 Ng, H. S., Koczwara, B., Roder, D., Chan, R. J., & Vitry, A. (2020). Patterns of health service utilisation among the Australian population with cancer compared with the general population. Australian Health Review, 44(3), 470-479.
DOI Scopus9 WoS8 Europe PMC5
2019 Ng, H. S., Vitry, A., Koczwara, B., Roder, D., & McBride, M. L. (2019). Patterns of comorbidities in women with breast cancer: a Canadian population-based study. Cancer causes & control, 30(9), 931-941.
DOI Scopus47 WoS45 Europe PMC42
2018 Ng, H. S., Roder, D., Koczwara, B., & Vitry, A. (2018). Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.. Asia-Pacific journal of clinical oncology, 14(2), e181-e192.
DOI Scopus59 WoS51 Europe PMC47
2018 Ng, H. S., Koczwara, B., Roder, D. M., Niyonsenga, T., & Vitry, A. I. (2018). Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis. Medical Journal of Australia, 208(1), 24-28.
DOI Scopus20 WoS19 Europe PMC18
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014. Cancer epidemiology, 54, 56-62.
DOI Scopus12 WoS11 Europe PMC8
2018 Ng, H. S., Koczwara, B., Roder, D., Niyonsenga, T., & Vitry, A. (2018). Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study. Journal of comorbidity, 8(1), 16-24.
DOI Europe PMC14
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study. Prostate cancer and prostatic diseases, 21(3), 403-410.
DOI Scopus47 WoS46 Europe PMC40
2013 Vitry, A. I., Ng, H. S., & Vitre, P. (2013). Assessment of the therapeutic value of new medicines marketed in Australia. Journal of pharmaceutical policy and practice, 6(article no. 2).
DOI

Connect With Me

Other Links